PIASy Mediates SUMO-2/3 Conjugation of Poly(ADP-ribose) Polymerase 1 (PARP1) on Mitotic Chromosomes

被引:42
|
作者
Ryu, Hyunju
Al-Ani, Gada
Deckert, Katelyn
Kirkpatrick, Donald [2 ]
Gygi, Steven P. [2 ]
Dasso, Mary [3 ]
Azuma, Yoshiaki [1 ]
机构
[1] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA
[2] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA
[3] NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20852 USA
基金
美国国家卫生研究院;
关键词
TOPOISOMERASE-II; SACCHAROMYCES-CEREVISIAE; PROTEIN SUMOYLATION; ACTIVE CENTROMERES; ENZYME; INTERACTS; CENPB; YEAST; BUB3;
D O I
10.1074/jbc.M109.074583
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
PIASy is a small ubiquitin-related modifier (SUMO) ligase that modifies chromosomal proteins in mitotic Xenopus egg extracts and plays an essential role in mitotic chromosome segregation. We have isolated a novel SUMO-2/3-modified mitotic chromosomal protein and identified it as poly(ADP-ribose) polymerase 1 (PARP1). PARP1 was robustly conjugated to SUMO-2/ 3 on mitotic chromosomes but not on interphase chromatin. PIASy promotes SUMOylation of PARP1 both in egg extracts and in vitro reconstituted SUMOylation assays. Through tandem mass spectrometry analysis of mitotically SUMOylated PARP1, we identified a residue within the BRCA1 C-terminal domain of PARP1 (lysine 482) as its primary SUMOylation site. Mutation of this residue significantly reduced PARP1 SUMOylation in egg extracts and enhanced the accumulation of species derived from modification of secondary lysine residues in assays using purified components. SUMOylation of PARP1 did not alter in vitro PARP1 enzyme activity, poly-ADP-ribosylation (PARylation), nor did inhibition of SUMOylation of PARP1 alter the accumulation of PARP1 on mitotic chromosomes, suggesting that SUMOylation regulates neither the intrinsic activity of PARP1 nor its localization. However, loss of SUMOylation increased PARP1-dependent PARylation on isolated chromosomes, indicating SUMOylation controls the capacity of PARP1 to modify other chromatin-associated proteins.
引用
收藏
页码:14415 / 14423
页数:9
相关论文
共 50 条
  • [31] Design, synthesis and SAR evaluation of imidazobenzodiazepines as potent poly(ADP-ribose)polymerase-1 (PARP1) inhibitors.
    Ferraris, D
    Pargas, R
    Dain, D
    Ginski, M
    Lautar, S
    Lee-Wisdom, K
    Liang, S
    Lin, Q
    Lu, XCM
    Morgan, L
    Thomas, B
    Tran, S
    Williams, L
    Xu, W
    Zhang, J
    Zao, YN
    Kalish, VJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U53 - U54
  • [32] Poly(ADP-ribose) Polymerase 1 (PARP1) restrains MyoD-dependent gene expression during muscle differentiation
    Matteini, Francesca
    Andresini, Oriella
    Petrai, Stefano
    Battistelli, Cecilia
    Rossi, Marianna Nicoletta
    Maione, Rossella
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [33] INVESTIGATION OF POLY (ADP-RIBOSE) POLYMERASE 1 (PARP1) AS A NOVEL THERAPEUTIC TARGET IN SMALL CELL LUNG CANCER (SCLC)
    Byers, Lauren A.
    Nilsson, Monique
    Fujimoto, Junya
    Saintigny, Pierre
    Wang, Jing
    Diao, Lixia
    Peyton, Michael
    Fan, You-Hong
    Giri, Uma
    Weber, Stephanie
    Duchemann, Boris
    Girard, Luc
    Coombes, Kevin
    Weinstein, John
    Minna, John D.
    Wistuba, Ignacio
    Heymach, John V.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1530 - S1531
  • [34] Role of Poly(ADP-ribose) Polymerase (PARP1) in Viral Infection and its Implication in SARS-CoV-2 Pathogenesis
    Rajawat, Jyotika
    Chandra, Abhishek
    CURRENT DRUG TARGETS, 2021, 22 (13) : 1477 - 1484
  • [35] The Pathogenic Role of Poly(ADP-ribose) Polymerase 1 (PARP-1) in Experimental Colitis
    Larmonier, Claire B.
    LaCasse, Collin J.
    Hill, Faihza M.
    Alizadeh, Darya
    Thurston, Robert D.
    Ghishan, Fayez K.
    Kiela, Pawel R.
    GASTROENTEROLOGY, 2012, 142 (05) : S885 - S886
  • [36] Poly(ADP-ribose) polymerase-1 (PARP-1) and its therapeutic implications
    Sodhi, Rupinder K.
    Singh, Nirmal
    Jaggi, Amteshwar S.
    VASCULAR PHARMACOLOGY, 2010, 53 (3-4) : 77 - 87
  • [37] POLY (ADP-RIBOSE) POLYMERASE-1 (PARP-1) INDUCES TROPHOBLAST SYNCYTIALIZATION
    Pater, Justin
    Shah, Girish
    MacPhee, Daniel
    PLACENTA, 2013, 34 (09) : A16 - A16
  • [38] Poly (ADP-RIBOSE) Polymerase-1 (PARP-1) modulates astrocyte activation
    Phulwani, NK
    Kielian, T
    JOURNAL OF NEUROCHEMISTRY, 2006, 96 : 44 - 44
  • [39] Poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors in cancer chemotherapy
    Cepeda, Victoria
    Fuertes, Miguel A.
    Castilla, Josefina
    Alonso, Carlos
    Quevedo, Celia
    Soto, Manual
    Perez, Jose M.
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2006, 1 (01) : 39 - 53
  • [40] Poly(ADP-ribose) polymerases in double-strand break repair: Focus on PARP1, PARP2 and PARP3
    Beck, Carole
    Robert, Isabelle
    Reina-San-Martin, Bernardo
    Schreiber, Valerie
    Dantzer, Francoise
    EXPERIMENTAL CELL RESEARCH, 2014, 329 (01) : 18 - 25